2019 - Fellow of the American Association for the Advancement of Science (AAAS)
Samuel M. Cohen mainly focuses on Carcinogen, Urinary bladder, Pathology, Internal medicine and Hyperplasia. The concepts of his Carcinogen study are interwoven with issues in Cancer research, Bioassay and Toxicity, Genotoxicity. Samuel M. Cohen interconnects Carcinogenesis, Cancer, Growth factor and Immunology in the investigation of issues within Cancer research.
His studies in Urinary bladder integrate themes in fields like Bladder cancer, Urine and Kidney. The study incorporates disciplines such as Rat Urinary Bladder and Cytotoxicity in addition to Pathology. His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Endocrinology.
Internal medicine, Carcinogen, Endocrinology, Urinary bladder and Pathology are his primary areas of study. His study in Urinary system, Toxicity and Bladder cancer is carried out as part of his studies in Internal medicine. His research integrates issues of Carcinogenesis, Cancer research, Pharmacology and Cell growth in his study of Carcinogen.
His Carcinogenesis research includes themes of Molecular biology and Mode of action. His Cancer research research integrates issues from Cancer, Immunology and Cytotoxicity. His study focuses on the intersection of Urinary bladder and fields such as Hyperplasia with connections in the field of Epithelium.
Samuel M. Cohen focuses on Cancer research, Carcinogen, Pharmacology, Carcinogenesis and Cancer. His Cancer research study also includes
His Pharmacology study integrates concerns from other disciplines, such as Hyperplasia and Cell growth. His Cancer research incorporates themes from Risk assessment, Bioassay and Genotoxicity. He focuses mostly in the field of Bioassay, narrowing it down to matters related to Urinary system and, in some cases, Pathology.
His primary areas of investigation include Carcinogen, Pharmacology, Carcinogenesis, Mode of action and Cancer. With his scientific publications, his incorporates both Carcinogen and Context. His Carcinogenesis study is related to the wider topic of Biochemistry.
His research in Mode of action focuses on subjects like Bioassay, which are connected to Human cell, Human cancer and Bioinformatics. His research in Cancer intersects with topics in Cell, Cellular receptor, Cancer research and Neuroscience. He interconnects Lung, Hyperplasia and Adenoma in the investigation of issues within Cell growth.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cell proliferation in carcinogenesis
Samuel M. Cohen;Leon B. Ellwein.
Genetic errors, cell proliferation, and carcinogenesis
Samuel Monroe Cohen;Leon B. Ellwein.
Cancer Research (1991)
A framework for human relevance analysis of information on carcinogenic modes of action.
M. E. Meek;John R. Bucher;Samuel Monroe Cohen;Vicki Dellarco.
Critical Reviews in Toxicology (2003)
Promoting Effect of Saccharin and dl-Tryptophan in Urinary Bladder Carcinogenesis
Samuel M. Cohen;Masayuki Arai;Jerome B. Jacobs;Gilbert H. Friedell.
Cancer Research (1979)
Epidemiology and etiology of bladder cancer
Sonny L. Johansson;Samuel Monroe Cohen.
Seminars in Surgical Oncology (1997)
Methylated Arsenicals: The Implications of Metabolism and Carcinogenicity Studies in Rodents to Human Risk Assessment
Samuel Monroe Cohen;Lora L Arnold;Michal Eldan;Ari S. Lewis.
Critical Reviews in Toxicology (2006)
The Nomenclature of Cell Death: Recommendations of an ad hoc Committee of the Society of Toxicologic Pathologists
Stuart Levin;Thomas J. Bucci;Samuel Monroe Cohen;Andrew S. Fix.
Toxicologic Pathology (1999)
The EH and SH3 domain Ese proteins regulate endocytosis by linking to dynamin and Eps15.
Ameet S. Sengar;Wei Wang;Joseph Bishay;Samuel Cohen.
The EMBO Journal (1999)
Mode of Action in Relevance of Rodent Liver Tumors to Human Cancer Risk
Michael P. Holsapple;Henri C. Pitot;Samuel Monroe Cohen;Alan R. Boobis.
Toxicological Sciences (2006)
Epidemiology and etiology of premalignant and malignant urothelial changes.
Samuel Monroe Cohen;Tomoyuki Shirai;Gunnar Steineck.
Scandinavian Journal of Urology and Nephrology (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: